None listed
Conditions
Interventions
Intervention 1: Intervention group: Group 500 mg of garlic supplementation and acute endurance activity. Intervention 2: Intervention group: Group 750 mg of garlic supplementation and acute endurance
Sponsors
Research Assistant-The university of Mohaghegh Ardabili
Eligibility
Sex/Gender
Male
Age
25 Years to 29 Years
Inclusion criteria
Inclusion criteria: Being Health Being active
Exclusion criteria
Exclusion criteria: Smoking History of cardiovascular disease, hypertension, lower leg injury, sleep disorders Drug, supplement and caffeine intake at least 48 hours before the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Factor VIII. Timepoint: Before supplementation, before and immediately after exercise. Method of measurement: Use the French Stage Kit by Coagulation Method and Using the Deficient Plasma.;Fibrinogen. Timepoint: Before supplementation, before and immediately after exercise. Method of measurement: Using Quantitative Fibrinogen Kit (Mahsa Yaran Iran) by Quantitative Method.;Systolic and diastolic blood pressure. Timepoint: Before supplementation, before and immediately after exercise. Method of measurement: Emsig Model Digital Barometer Manufacturing Made in Japan.;Thromboplastin time. Timepoint: Before supplementation, before and immediately after exercise. Method of measurement: using a French Stage Kit with an ACI 7000 device, using a coagulometric method.;Prothrombin time. Timepoint: Before supplementation, before and immediately after exercise. Method of measurement: using a French Stage Kit with an ACI 7000 device, using a coagulometric method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmeneh Pourrahim Ghouroghchi
The university of Mohaghegh Ardabili
Outcome results
None listed